Report Code: A16968 | Jun 2022 | Pages: 150 | ||
Tables: 142 | Charts: 57 |
|
The global unilateral biportal endoscopy market size was $295.31 million in 2021, and is projected to reach $548.43 million by 2031, growing at a CAGR of 6.4% from 2022 to 2031. UBE procedures use endoscopic equipment and supplies to perform unilateral biportal endoscopic spine surgery. They are minimally invasive or non-surgical treatments. Numerous instruments and pieces of equipment, such as procedure-specific scopes, video monitors, imaging tools, anesthetic monitoring tools, light sources, video processors, insufflators, endoscope cabinets, and endoscopy carts or trolleys, are used during endoscopy to ensure a safe and efficient procedure. The primary users of endoscopic equipment include gastroenterologists, gynecologists, nephrologists, neurologists, cardiologists, hepatologists, and surgeons who perform liver transplants. The use of tiny tubes, handheld cameras, and surgical instruments through one or more tiny incisions constitutes the minimally invasive surgical procedure known as an endoscopy. Less pain, a shorter or no hospital stay, or fewer issues with pre- and post-surgery care are the main advantages of UBE endoscopic procedures. As a result, these procedures are less expensive, more efficient, and safer than conventional open operations. The U.S., Canada, UK, Germany, Australia, and a few Middle Eastern countries like the UAE have health insurance companies that cover these procedures further providing unilateral biportal endoscopy market opportunity.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe, owing to the COVID-19 pandemic. State-run administrations across the globe declared inescapable lockdowns as well as social distancing measures to forestall breakdown of the healthcare structure. States have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries and the enhanced response toward these regulations affects the industry. The distribution, production, and store network have been impacted, due to lockdowns across the globe. In addition, the UBE market had a negative impact during the pandemic. All elective procedures were either cancelled or postponed due to the overcrowding of COVID-19 cases in hospitals. Due to reduction in endoscopic procedures across the world and the success rate of this treatment was decreased. Contrary to other surgical procedures, UBE endoscope sales have increased as fewer hospitals and clinics are able to follow and put into practice the exacting COVID-19 guidelines proposed by governing bodies. To reduce the danger of infection, it is advised to employ personal protective equipment, negative pressure suites, and ward isolation. As a result, UBE endoscopic therapy has become expensive overall. The UBE endoscopy market's expansion in 2020 has been constrained by these issues. The market is anticipated to rebound in the upcoming years which will be anticipated by the widespread use of vaccines.
The growth of the unilateral biportal endoscopy market size is driven by need to diagnose and treat a number of serious spinal disorders such as spinal stenosis and herniated discs. Although, UBE doctors and surgeons are in great demand all around the world, with the exception of the UK, where the United Kingdom Central Council for Nursing, Midwifery, and Health has been training nurse UBE for the past ten years, this scarcity of skilled workers in endoscopy is also anticipated throughout Asia-Pacific, Latin America, and Europe. In addition, this scarcity has been seen as a major restraint in the market. To address this issue, a few industry participants, including Olympus, have set up training facilities. The business operates 22 endoscopic training facilities in Asia alone. Such activities will raise knowledge of the most recent developments in endoscopy technology and boost the pool of qualified endoscopic experts.
Furthermore, players in the UBE endoscopy equipment market are encouraged to increase their presence in emerging nations by surge in prevalence of cancer, quick advancements in healthcare infrastructure, rapid expansion of medical tourism, and lax regulatory environments present in these nations. The Middle East, Latin America, and Asia-Pacific are now witnessing a rise in the establishment of UBE endoscopic equipment manufacturing facilities. Important companies like Stryker and KARL STORZ have already established their production and R&D centers in these nations.
The UBE market is segmented on the basis of product type, indication, end user, and region. By product type, the market is bifurcated into endoscope and accessory devices. By indication the market is classified into herniated discs, spinal stenosis and others. The others segment is further segmented into scoliosis, degenerative disc disease. By end user, the market is fragmented into hospitals and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product Type Segment Review
By product type, the endoscopy segment held largest unilateral biportal endoscopy market share in 2021. The growth of this segment is attributed to technological advancements in endoscopes offering image-guided technology with Artificial Intelligence (AI) and machine learning gaining popularity in the field. The accessory devices segment is expected to show fastest unilateral biportal endoscopy market growth due to increasing use of accessories in various surgical procedures.
Indication Segment Review
By indication, the herniated discs segment was the highest revenue contributor to the market in 2021 and is set to maintain its position through unilateral biportal endoscopy market forecast. The growth of this segment is attributed to increasing number of patients undergoing endoscopic procedures for herniated discs. Moreover, spinal stenosis segment is set to be the fastest growing segment with a CAGR of 7.2% owing to minimized collateral tissue damage and faster recovery.
End User Segment Review
By end user, the hospitals segment was the highest revenue contributor to the market in 2021. The growth of this segment is attributed to the presence of sophisticated surgical equipment in these settings. Additionally, the ambulatory surgical centers segment is anticipated to be the fastest growing segment due to increasing number of healthcare professionally-owned ambulatory care settings to cater to the rising demand for minimally invasive surgeries.
Region Segment Review
Region wise, North America was the highest revenue contributor in 2021. The growth of this segment is attributed to the favorable reimbursement policies for endoscopic procedures in the U.S., high investments by hospitals to purchase new endoscopic equipment, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals. Asia Pacific is set to grow at a highest CAGR due to surge in medical expertise and technological advancement in medical sector.
Key players that operate in the global UBE market are CONMED Corporation, Endovision Co. Ltd., Jiangsu Bonss Medical Technology Co. Ltd., Joimax GmbH, Karl Storz, Maxmorespine, Maxer Endoscopy GmbH, Richard Wolf, Smith & Nephew and Stryker Corporation.
Unilateral Biportal Endoscopy Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Indication |
|
By End User |
|
By Region |
|
Key Market Players | Endovision Co. Ltd., Smith & Nephew, CONMED Corporation, Stryker Corporation, Karl Storz, Maxer Endoscopy GmbH, Richard Wolf, Joimax GmbH, Kinetix Lifesciences, Jiangsu Bonss Medical Technology Co. Ltd. |
This section provides various opinions of top-level CXOs in the unilateral biportal endoscopy (UBE) industry. In accordance to several interviews conducted, the endoscopy devices market is expected to witness a healthy growth with the rise in demand for minimally invasive surgical procedures. The UBE endoscopy devices market has enhanced interest of the healthcare industry, owing to rise in number of UBE endoscopy procedures and increase in use of these devices in emerging applications to diagnose and treat abnormalities of internal organs and cavities.
In addition, favorable FDA approvals & reimbursement policies pertaining to UBE endoscopy devices in developed economies, surge in patient preference for minimally invasive surgeries, and shorter recovery time & minimal postoperative complications drive the growth of the global UBE endoscopy devices market. However, dearth of trained physicians & endoscopists and infections caused by few endoscopes restrict the growth of the market. On the contrary, unmet medical demands in developing countries are expected to provide remunerative opportunities for market expansion.
According to the perspectives of CXOs of leading companies in the market, enhanced treatment options with high success rate, patient preference toward minimally invasive surgeries, and technological advancements are some major factors that drive the growth of the global UBE endoscopy market. However, stringent regulations, high cost of treatment, and low reimbursement policies hamper the market growth. Presently, endoscopes and accessory devices are the most preferred product type in the UBE endoscopy market.
According to CXOs, increase in awareness regarding technologically advanced devices and rise in knowledge about novel devices are expected to boost the demand for UBE endoscopy devices. Therefore, use of UBE endoscopy devices is expected to increase in the future. In addition, use of UBE endoscopy devices is highest in North America, specially the U.S., owing to increase in incidences of targeted diseases, higher government expenditure on healthcare, followed by Europe, and Asia-Pacific
A. The estimated industry size of Unilateral biportal endoscopy market is $295.31 Million in 2021.
A. Spinal decompression surgery is the leading application of Unilateral biportal endoscopy market.
A. The upcoming trends of unilateral biportal endoscopy market are attributed to technological advancements in endoscopes offering image-guided technology with Artificial Intelligence (AI) and machine, learning gaining popularity in the field, treat a number of serious spinal disorders such as spinal stenosis and herniated discs.
A. North America is the largest regional market for Unilateral biportal endoscopy market.
A. CONMED Corporation, Endovision Co. Ltd., Jiangsu Bonss Medical Technology Co. Ltd., Joimax GmbH, Karl Storz, Maxmorespine, Maxer Endoscopy GmbH, Richard Wolf, Smith & Nephew and Stryker Corporation hold the market share in Unilateral biportal endoscopy market.
Start reading instantly.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers